BIOCRYST PHARMACEUTICALS, INC. Inventory, Finished Goods, Net of Reserves
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Inventory, Finished Goods, Net of Reserves of $1.31 million as of 2015-06-30, per its 10-Q filed 2015-08-07.
Discontinued › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2016-02-26
- 2015-06-30: Inventory, Finished Goods, Net of Reserves $1.31M.
- 2015-03-31: Inventory, Finished Goods, Net of Reserves $1.21M.
- 2014-12-31: Inventory, Finished Goods, Net of Reserves $416.00K.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2015-06-30 | $1.31M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $1.21M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $416.00K 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |